Menopause Completed Phase 3 Trials for Estradiol (DB00783)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01942668A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor SymptomsTreatment
NCT02224313Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal WomenBasic Science
NCT00464971Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension TrialTreatment
NCT00465192Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic VaginitisTreatment
NCT00108849Vagifem Low Dose for Postmenopausal Atrophic Vaginitis SymptomsTreatment
NCT00431132Endometrial Safety of a Low Dose of VagifemĀ® in Postmenopausal Women With Atrophic VaginitisTreatment
NCT02253173Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal WomenTreatment